LEO Pharma to Present 21 Posters Across Chronic Hand Eczema, Generalized Pustular Psoriasis, Atopic Dermatitis and Pyoderma Gangrenosum at the 2026 Fall Clinical Dermatology Conference
LEO Pharma, Inc., a global leader in medical dermatology, today announced its scientific program for the 2026 Fall Clinical Dermatology Conference, taking place October 8-11 in Las Vegas, Nevada. Among the 21 posters are presentations of new data on delgocitinib in chronic hand eczema (CHE), spesolimab in generalized pustular psoriasis (GPP), and tralokinumab in atopic dermatitis (AD). Other presentations include findings to characterize disease prevalence and burden among people with CHE, GPP and pyoderma gangrenosum (PG).1-21
